Trials
Search / Trial NCT05637866

SRMA of the Effect of Soy Milk vs Cow's Milk on Cardiometabolic Outcomes

Launched by UNIVERSITY OF TORONTO · Nov 28, 2022

Apply for Trial

Trial Information

Current as of January 16, 2025

Active, not recruiting

Keywords

Cholesterol Triglycerides Apolipoprotein B Hemoglobin A1c Fasting Plasma Glucose Fasting Plasma Insulin 2hr Plasma Glucose Body Weight Body Mass Index Body Fat Waist Circumference Blood Pressure Adiposity Fatty Liver Nafld Crp Inflammation Hdl C Ldl C Non Hdl C Intrahepatocellular Lipids Alt Ast

ClinConnect Summary

RATIONALE. Soymilk and other processed soy products are at an important crossroads. Although the DGA, Health Canada, and various pediatric associations recognize fortified soymilk as the only non-dairy plant milk alternative equivalent to cow's milk and it can carry an approved health claim for coronary heart disease risk reduction based on the soy protein that it contains, soymilk is classified by the NOVA classification as an ultra-processed food (the opposite of the classification of cow's milk as an unprocessed or minimally processed food). To be an acceptable iso-sweet alternative to c...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Randomized controlled trials
  • • Soy milk intervention
  • • Cow's milk comparator
  • • Intervention duration ≥ 3 weeks
  • • Data for at least 1 outcome
  • Exclusion Criteria:
  • • Non-human studies
  • • Observational studies
  • • Acute single-bolus feeding studies
  • • Participants \< 18 years of age
  • • Multimodal interventions
  • • Lack of suitable comparator
  • • Intervention duration \< 3 weeks
  • • No viable outcome data

Trial Officials

John L. Sievenpiper, MD,PhD,FRCPC

Principal Investigator

University of Toronto

About University Of Toronto

The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.

Locations

Toronto, Ontario, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials